Qnomx AG is an AI-powered genomic data interpretation platform that automates the analysis of cancer genomic profiles from next-generation sequencing (NGS) reports. The platform transforms complex genomic data into concise, clinically relevant summaries for oncology labs and clinicians, reducing expert workload per NGS case by up to 85%. It enables faster, more consistent treatment decisions with a 'human in the loop' approach, ensuring accuracy and auditability. The system integrates seamlessly into existing lab workflows and is designed to be compliant with IVDR, MDR, and the European AI Act, positioning it as the world’s first regulatory-grade generative AI solution for clinical decision support in oncology.